why choose us

First received: December 18, 2024

Clinical Trial: Real-World Immuno-Radiotherapy for Advanced NSCLC

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Lung Cancer Non-Small Cell Cancer (NSCLC)

Study Type: OBSERVATIONAL


Official Title: Real-world Survival Outcomes and the Evaluation of Optimal Strategies for Immuno-Radiotherapy in Advanced Non-Small-Cell Lung Cancer: a Territory-wide Study (OCEANUS Study)

Brief Summary: The optimal combination strategy for radiotherapy combined with immunotherapy (iRT) in advanced non-small-cell lung cancer (NSCLC) remains unclear, and there is a lack of real-world data to validate its efficacy.The objective of this study is to confirm the survival benefits of iRT in advanced NSCLC and to identify the optimal combination strategy for its use.

Read more